No photo of Melanie M.A. Lindenberg

Melanie M.A. Lindenberg

  • 12 Citations
  • 2 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Melanie M.A. Lindenberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Biomedical Technology Assessment Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Sensitivity and Specificity Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 12 Citations
  • 2 h-Index
  • 2 Article
  • 1 Meeting Abstract
  • 1 Review article
2 Citations (Scopus)
21 Downloads (Pure)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation

Retel, V. P., Steuten, L. M. G., Foppen, M. H. G., Mewes, J. C., Lindenberg, M. A., Haanen, J. B. A. G. & van Harten, W. H., 15 Sep 2018, In : BMC cancer. 18, 1, 895.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
10 Downloads (Pure)

Treatment with Tumor-infiltrating Lymphocytes in Advanced Melanoma Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product

Lindenberg, M. A., Retl, V. P., van den Berg, J. H., Geukes Foppen, M. H., Haanen, J. B. & Van Harten, W. H., 1 Nov 2018, In : Journal of Immunotherapy. 41, 9, p. 413-425 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Tumor-Infiltrating Lymphocytes
Melanoma
Biomedical Technology Assessment
Therapeutics
Financial Support

Evaluation of early implementation of tumor-infiltrating lymphocytes in treating advanced melanoma in an academic setting: a constructive technology analysis

Lindenberg, M. A., Retèl, V. P., Foppen, M. H. G., van den Berg, J., Haanen, J. & van Harten, W. H., 29 Jan 2017, In : European journal of cancer. 72, S1, p. S130-S131 1263.

Research output: Contribution to journalMeeting AbstractAcademic

10 Citations (Scopus)

Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review

Lindenberg, M. M. A., Miquel Cases, A., Retèl, V. P., Sonke, G. S., Wesseling, J., Stokkel, M. P. M. & van Harten, W. H., 1 Apr 2017, In : Critical Reviews in Oncology/Hematology. 112, p. 198-207 10 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Sensitivity and Specificity
Triple Negative Breast Neoplasms